| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,030 |
4,379 |
$124K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,218 |
1,470 |
$57K |
| 99233 |
Prolong inpt eval add15 m |
2,852 |
951 |
$55K |
| 99223 |
Prolong inpt eval add15 m |
1,599 |
1,540 |
$40K |
| J9271 |
Injection, pembrolizumab, 1 mg |
16 |
12 |
$37K |
| 99215 |
Prolong outpt/office vis |
1,435 |
1,333 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
884 |
846 |
$19K |
| 96367 |
|
773 |
488 |
$17K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,358 |
917 |
$15K |
| J0897 |
Injection, denosumab, 1 mg |
25 |
25 |
$11K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
593 |
228 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,238 |
786 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
173 |
105 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
742 |
332 |
$3K |
| 96417 |
|
305 |
227 |
$2K |
| 99205 |
Prolong outpt/office vis |
55 |
55 |
$1K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
102 |
28 |
$671.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
718 |
290 |
$626.49 |
| J3490 |
Unclassified drugs |
154 |
100 |
$358.47 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
453 |
289 |
$292.52 |
| 96415 |
|
31 |
24 |
$134.01 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
241 |
138 |
$67.73 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
175 |
110 |
$43.17 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
97 |
66 |
$20.78 |